Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03116412

A Prospective Randomized Multicenter Trial to Assess Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma

Led by Uppsala University · Updated on 2024-12-16

1300

Participants Needed

20

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating whether regular radiological assessments during follow-up after surgery for high-risk malignant melanoma improve patient survival. The study addresses concerns about the resource demands, potential radiation exposure, and anxiety caused by such imaging, especially given the recent introduction of effective medical treatments for melanoma. There is currently no clear evidence supporting routine imaging in this context. Participants are randomly assigned to one of two groups. One group follows national guidelines with regular doctor appointments for 3 years, while the other group receives the same follow-up plus additional whole-body CT or PET scans and blood tests at baseline, 6, 12, 24, and 36 months. An interim analysis will be done after 1,000 patients enroll. During the study, researchers will monitor overall survival at 5 years as the primary outcome. They will also assess quality of life through questionnaires over the 3-year follow-up. Participants will attend scheduled visits for clinical evaluations, imaging, and blood tests, with the study aiming to provide clear evidence about the role of imaging in post-surgical melanoma care.

CONDITIONS

Brief Title

A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 18 years of age
  • Radical surgery for Cutaneous Malignant Melanoma stage IIb-c and III
  • Sufficient renal function for intravenous contrast scans
Not Eligible

You will not qualify if you...

  • Assessed as unfit to receive treatment if melanoma recurs
  • Life expectancy less than 2 years due to other serious diseases
  • Unable or unwilling to provide informed consent
  • Unable to comply with follow-up program
  • Participation in other clinical trials affecting follow-up
  • Other malignancies within past 5 years except certain in situ cancers
  • Pregnancy or planned pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 3 years

Participants are assigned to routine follow-up or follow-up with additional radiological assessments including CT or PET scans and blood tests.

5 visits for scans and blood tests at baseline, 6, 12, 24, and 36 months

Long-term Monitoring

Duration - Up to 3 years

Participants continue follow-up with regular doctor's appointments according to national guidelines for ongoing assessment.

Regular doctor’s appointments as per national guidelines

Trial Site Locations

Total: 20 locations

1

Södra Älvsborgs sjukhus

Borås, Sweden

Terminated

2

Mälarsjukhuset Eskilstuna

Eskilstuna, Sweden

Actively Recruiting

3

Falu lasarett

Falun, Sweden

Actively Recruiting

4

Gävle sjukhus

Gävle, Sweden

Actively Recruiting

5

Department of Surgery, Sahlgrenska University Hospital

Gothenburg, Sweden

Actively Recruiting

6

Helsingborgs lasarett

Helsingborg, Sweden

Actively Recruiting

7

Länssjukhuset Ryhov

Jönköping, Sweden

Actively Recruiting

8

Länssjukhuset i Kalmar

Kalmar, Sweden

Not Yet Recruiting

9

Centralsjukhuset i Karlstad

Karlstad, Sweden

Actively Recruiting

10

Linköping University Hospital

Linköping, Sweden

Actively Recruiting

11

Skåne University Hospital

Malmö, Sweden

Actively Recruiting

12

Örebro University Hospital

Örebro, Sweden

Actively Recruiting

13

Skaraborgs sjukhus Skövde

Skövde, Sweden

Terminated

14

Karolinska University Hospital

Stockholm, Sweden

Actively Recruiting

15

Länssjukhuset Sundsvall

Sundsvall, Sweden

Actively Recruiting

16

Uddevalla sjukhus

Uddevalla, Sweden

Terminated

17

Umeå University Hospital

Umeå, Sweden

Terminated

18

Akademiska sjukhuset

Uppsala, Sweden

Actively Recruiting

19

Västmanlands sjukhus Västerås

Västerås, Sweden

Actively Recruiting

20

Visby lasarett

Visby, Sweden

Actively Recruiting

Loading map...

Research Team

G

Gustav J Ullenhag, professor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

A Phase 2, Randomized, Double-Blind Study of Intismeran Auto...

Malignant Melanoma

Actively Recruiting

38 locations

A Phase 1, Open-Label, Multiple-Ascending Dose Study of the ...

Non Small Cell Lung Cancer

Actively Recruiting

9 locations

Phase I First in Human Study of CBA-1205, Anti-DLK1 Monoclon...

Solid Tumors

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden.

Cecilia O Ladjevardi, Ylva Naeser, Ulf Dyrke...

https://pubmed.ncbi.nlm.nih.gov/41167217

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma.

Ylva Naeser, Hildur Helgadottir, Yvonne Brandberg...

https://pubmed.ncbi.nlm.nih.gov/33287744